Alexion Europe | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,244 results for “Alexion Europe”

CHMP Backs AstraZeneca's Klygefa (gefurulimab) for Generalised Myasthenia Gravis in the EU

CHMP Backs 12 New Medicines, Including First Oral Daily Hidradenitis Suppurativa Option and Earlier-Line Tecvayli

Federal Court upholds Alexion patent, blocks Amgen biosimilar ...

Monopar Acquires Late-Stage Wilson Disease Drug Candidate ALXN-1840 from Alexion

AstraZeneca Discontinues Two Alexion Rare Disease Programs Amid Strong Q4 Performance

Monopar Acquires Late-Stage Wilson Disease Drug Candidate ALXN-1840 from Alexion, AstraZeneca Rare Disease

JCR Pharmaceuticals Licenses JUST-AAV Gene Therapy Platform to Alexion in $825 Million Deal

Alexion Partners with Pangaea Data to Develop AI System for Hypophosphatasia Detection

Alexion Launches Phase 3 Trial of Ultomiris for Severe COVID-19 Pneumonia

Alexion Launches Interactive Storybook to Help Children Understand Rare Kidney Disease aHUS

Page 1 of 389